252 related articles for article (PubMed ID: 16049337)
21. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
22. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
23. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
Zhao R; Hu W; Tsai J; Li W; Gan WB
Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
[TBL] [Abstract][Full Text] [Related]
24. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
[TBL] [Abstract][Full Text] [Related]
26. Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease.
Darvesh S; Cash MK; Reid GA; Martin E; Mitnitski A; Geula C
J Neuropathol Exp Neurol; 2012 Jan; 71(1):2-14. PubMed ID: 22157615
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
29. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
30. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.
Yan P; Bero AW; Cirrito JR; Xiao Q; Hu X; Wang Y; Gonzales E; Holtzman DM; Lee JM
J Neurosci; 2009 Aug; 29(34):10706-14. PubMed ID: 19710322
[TBL] [Abstract][Full Text] [Related]
32. In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques.
Burgold S; Filser S; Dorostkar MM; Schmidt B; Herms J
Acta Neuropathol Commun; 2014 Mar; 2():30. PubMed ID: 24678659
[TBL] [Abstract][Full Text] [Related]
33. Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology.
Zhu Y; Obregon D; Hou H; Giunta B; Ehrhart J; Fernandez F; Mori T; Nikolic W; Zhao Y; Morgan D; Town T; Tan J
J Cell Mol Med; 2011 Feb; 15(2):327-38. PubMed ID: 19900216
[TBL] [Abstract][Full Text] [Related]
34. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
[TBL] [Abstract][Full Text] [Related]
36. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
37. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
[TBL] [Abstract][Full Text] [Related]
38. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
[TBL] [Abstract][Full Text] [Related]
40. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
